oxophenylarsine has been researched along with Granulocytic Leukemia in 2 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Q | 1 |
| Matta, H | 1 |
| Chaudhary, PM | 1 |
| Estrov, Z | 1 |
| Manna, SK | 1 |
| Harris, D | 1 |
| Van, Q | 1 |
| Estey, EH | 1 |
| Kantarjian, HM | 1 |
| Talpaz, M | 1 |
| Aggarwal, BB | 1 |
2 other studies available for oxophenylarsine and Granulocytic Leukemia
| Article | Year |
|---|---|
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Topics: Acetylcysteine; Acute Disease; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Transfor | 2003 |
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenicals; Caspase 3; Caspase Inhibitors; Cell Div | 1999 |